Hiscox Ltd
F:H2X3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hiscox Ltd
F:H2X3
|
BM |
|
Wanderport Corp
OTC:WDRP
|
US |
|
Gentera SAB de CV
OTC:CMPRF
|
MX |
|
Onconetix Inc
NASDAQ:ONCO
|
US |
|
M
|
My City Builders Inc
OTC:MYCB
|
US |
|
Appili Therapeutics Inc
TSX:APLI
|
CA |
|
C
|
Com-Guard.Com Inc
OTC:CGUD
|
US |
Wall Street
Price Targets
H2X3 Price Targets Summary
Hiscox Ltd
According to Wall Street analysts, the average 1-year price target for
H2X3
is 17.53 EUR
with a low forecast of 12.25 EUR and a high forecast of 20.86 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is H2X3's stock price target?
Price Target
17.53
EUR
According to Wall Street analysts, the average 1-year price target for
H2X3
is 17.53 EUR
with a low forecast of 12.25 EUR and a high forecast of 20.86 EUR.
What is Hiscox Ltd's Revenue forecast?
Projected CAGR
8%
For the last 14 years the
compound annual growth rate for
Hiscox Ltd's revenue is
7%.
The projected
CAGR
for the next 3 years is
8%.
What is Hiscox Ltd's Net Income forecast?
Projected CAGR
10%
For the last 14 years the
compound annual growth rate for
Hiscox Ltd's net income is
23%.
The projected
CAGR
for the next 3 years is
10%.
